A diagnostic genetic test for the physical mapping of germline rearrangements in the susceptibility breast cancer genes BRCA1 and BRCA2

Human Mutation

Volumn 33, Issue 6, 2012, Pages 998-1009

  Cheeseman, Kevin ^a   Rouleau, Etienne ^b   Vannier, Anne ^a   Thomas, Aurélie ^a   Briaux, Adrien ^b   Lefol, Cedrick ^b   Walrafen, Pierre ^a   Bensimon, Aaron ^a   Lidereau, Rosette ^b   Conseiller, Emmanuel ^a   Ceppi, Maurizio ^a  

^a Genomic Vision   (France)

^b INSTITUT CURIE   (France)

Author keywords

Brca1; Brca2; Breast cancer; Genomic morse code; Molecular combing; Rearrangements

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

5' UNTRANSLATED REGION; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA DETERMINATION; EXON; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE DUPLICATION; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC SCREENING; GERM LINE; HUMAN; INTRON; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TANDEM REPEAT;

BREAST NEOPLASMS; EARLY DETECTION OF CANCER; EXONS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC TESTING; GERM-LINE MUTATION; HUMANS; OVARIAN NEOPLASMS; PHYSICAL CHROMOSOME MAPPING; REPRODUCIBILITY OF RESULTS; TRANSLOCATION, GENETIC;

EID: 84865182680     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.22060     Document Type: Article

References (49)

1. Agata S, Viel A, Della Puppa L, Cortesi L, Fersini G, Callegaro M, Dalla Palma M, Dolcetti R, Federico M, Venuta S, and others. 2006. Prevalence of BRCA1 genomic rearrangements in a large cohort of Italian breast andbreast/ovarian cancer families without detectable BRCA1 and BRCA2 point mutations. Genes Chromosomes Cancer 45:791-797.
2. Altman DG, Bland JM. 1994. Diagnostic tests. 1: Sensitivity and specificity. BMJ 308:1552.
3. Armaou S, Konstantopoulou I, Anagnostopoulos T, Razis E, Boukovinas I, Xenidis N, Fountzilas G, Yannoukakos D. 2007. Novel genomic rearrangements in the BRCA1 gene detected in Greek breast/ovarian cancer patients. Eur J Cancer 43:443-453.
4. Barrois M, Bieche I, Mazoyer S, Champeme MH, Bressac-de Paillerets B, Lidereau R. 2004. Real-time PCR-based genedosage assay for detecting BRCA1rearrangements in breast-ovarian cancer families. Clin Genet 65:131-136.
5. Caburet S, Conti C, Schurra C, Lebofsky R, Edelstein SJ, Bensimon A. 2005. Human ribosomal RNA gene arrays display a broad range of palindromic structures. Genome Res 15:1079-1085.
6. Caputo S, Benboudjema L, Sinilnikova O, Rouleau E, Béroud C, Lidereau R; French BRCA GGC Consortium. 2012. Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMDBRCA1/BRCA2 databases. Nucleic Acids Res 40:D992-1002.
7. Casilli F, Di Rocco ZC, Gad S, Tournier I, Stoppa-Lyonnet D, Frebourg T, Tosi M. 2002. Rapid detection of novel BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments. Hum Mutat 20:218-226.
8. Caux-Moncoutier V, Castera L, Tirapo C, Michaux D, Remon MA, Lauge A, Rouleau E, De Pauw A, Buecher B, Gauthier-Villars M and others. 2011. EMMA, a cost- and time-effective diagnostic method for simultaneous detection of point mutations and large-scale genomic rearrangements: application to BRCA1 and BRCA2 in 1,525 patients. Hum Mutat 32:325-334.
9. Cavalieri S, Funaro A, Pappi P, Migone N, Gatti RA, Brusco A. 2008. Large genomic mutations within the ATM gene detected by MLPA, including a duplication of 41 kb from exon 4 to 20. Ann Hum Genet 72:10-18.
10. Charbonnier F, Raux G, Wang Q, Drouot N, Cordier F, Limacher JM, Saurin JC, Puisieux A, Olschwang S, Frebourg T. 2000. Detection of exon deletions and duplications of the mismatch repair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments. Cancer Res 60:2760-2763.
11. de Juan I, Esteban E, Palanca S, Barragan E, Bolufer P. 2009. High-resolution melting analysis for rapid screening of BRCA1 and BRCA2 Spanish mutations. Breast Cancer Res Treat 115:405-414.
12. De Leeneer K, Hellemans J, De Schrijver J, Baetens M, Poppe B, Van Criekinge W, De Paepe A, Coucke P, Claes K. 2011. Massive parallel amplicon sequencing of the breast cancer genes BRCA1 and BRCA2: opportunities, challenges, and limitations. Hum Mutat 32:335-344.
13. Engert S, Wappenschmidt B, Betz B, Kast K, Kutsche M, Hellebrand H, Goecke TO, Kiechle M, Niederacher D, Schmutzler RKand others. 2008. MLPAscreening in the BRCA1 gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases. Hum Mutat 29:948-958.
14. Foretova L, Petrakova K, Palacova M, Kalabova R, Navratilova M, Lukesova M, Vasickova P, Machackova E, Kleibl Z, Pohlreich P. 2006. Genetic and preventive services for hereditary breast and ovarian cancer in the czech republic. Hered Cancer Clin Pract 4:3-6.
15. Frolov A, Prowse AH, Vanderveer L, Bove B, Wu H, Godwin AK. 2002. DNA arraybased method for detection of large rearrangements in the BRCA1 gene. Genes Chromosomes Cancer 35:232-241.
16. Gad S, Aurias A, Puget N, Mairal A, Schurra C, Montagna M, Pages S, Caux V, Mazoyer S, Bensimon A and others. 2001. Color bar coding the BRCA1 gene on combed DNA: a useful strategy for detecting large gene rearrangements. Genes Chromosomes Cancer 31:75-84.
17. Gad S, Bieche I, Barrois M, Casilli F, Pages-Berhouet S, Dehainault C, Gauthier-Villars M, Bensimon A, Aurias A, Lidereau R and others. 2003. Characterisation of a 161 kb deletion extending from the NBR1 to the BRCA1 genes in a French breastovarian cancer family. Hum Mutat 21:654.
18. Gad S, Caux-Moncoutier V, Pages-Berhouet S, Gauthier-Villars M, Coupier I, Pujol P, Frenay M, Gilbert B, Maugard C, Bignon YJ, and others. 2002a. Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families. Oncogene 21:6841-6847.
19. Gad S, Klinger M, Caux-Moncoutier V, Pages-Berhouet S, Gauthier-Villars M, Coupier I, Bensimon A, Aurias A, Stoppa-Lyonnet D. 2002b. Bar code screening on combed DNA for large rearrangements of the BRCA1 and BRCA2 genes in French breast cancer families. J Med Genet 39:817-821.
20. Gaudet MM, Kirchhoff T, Green T, Vijai J, Korn JM, Guiducci C, Segre AV, McGee K, McGuffog L, Kartsonaki C and others. 2010. Common genetic variants andmodification of penetrance of BRCA2-associated breast cancer. PLo S Genet 6:e1001183.
21. Hansen TO, Jonson L, Albrechtsen A, Andersen MK, Ejlertsen B, Nielsen FC. 2009. Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families. Breast Cancer Res Treat 115:315-323.
22. Hastings PJ, Lupski JR, Rosenberg SM, Ira G. 2009. Mechanisms of change in gene copy number. Nat Rev Genet 10:551-564.
23. Herrick J, Bensimon A. 2009. Introduction to molecular combing: genomics, DNA replication, and cancer. Methods Mol Biol 521:71-101.
24. Hofmann W, Wappenschmidt B, Berhane S, Schmutzler R, Scherneck S. 2002. Detection of large rearrangements of exons 13 and 22 in the BRCA1 gene in German families. J Med Genet 39:E36.
25. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. 2011. Global cancer statistics. CA Cancer J Clin 61:69-90.
26. King MC, Marks JH, Mandell JB. 2003. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643-646.
27. Lebofsky R, Heilig R, Sonnleitner M, Weissenbach J, Bensimon A. 2006. DNAreplication origin interference increases the spacing between initiation events in human cells. Mol Biol Cell 17:5337-5345.
28. Lim YK, Lau PT, Ali AB, Lee SC, Wong JE, Putti TC, Sng JH. 2007. Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer. Clin Genet 71:331-342.
29. Mazoyer S. 2005. Genomic rearrangements in the BRCA1 and BRCA2 genes. Hum Mutat 25:415-422.
30. Montagna M, Dalla Palma M, Menin C, Agata S, De Nicolo A, Chieco-Bianchi L, D'Andrea E. 2003. Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families. Hum Mol Genet 12:1055-1061.
31. Nathanson KL, Wooster R, Weber BL. 2001. Breast cancer genetics: what we know and what we need. Nat Med 7:552-556.
32. Nguyen K, Walrafen P, Bernard R, Attarian S, Chaix C, Vovan C, Renard E, Dufrane N, Pouget J, Vannier A and others. 2011. Molecular combing reveals allelic combinations in facioscapulohumeral dystrophy. Ann Neurol 70:627-633.
33. Payne SR, Newman B, King MC. 2000. Complex germline rearrangement of BRCA1 associated with breast and ovarian cancer. Genes Chromosomes Cancer 29:58-62.
34. Pertesi M, Konstantopoulou I, Yannoukakos D. 2011. Haplotype analysis of two recurrent genomic rearrangements in the BRCA1 gene suggests they are founder mutations for the Greek population. Clin Genet 80:375-382.
35. Petrij-Bosch A, Peelen T, van Vliet M, van Eijk R, Olmer R, Drusedau M, Hogervorst FB, Hageman S, Arts PJ, Ligtenberg MJand others. 1997. BRCA1genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 17:341-345.
36. Preisler-Adams S, Schonbuchner I, Fiebig B, Welling B, Dworniczak B, Weber BH. 2006. Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin. Cancer Genet Cytogenet 168:44-49.
37. Puget N, Gad S, Perrin-Vidoz L, Sinilnikova OM, Stoppa-Lyonnet D, Lenoir GM, Mazoyer S. 2002. Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot. Am J Hum Genet 70:858-865.
38. Puget N, Sinilnikova OM, Stoppa-Lyonnet D, Audoynaud C, Pages S, Lynch HT, Goldgar D, Lenoir GM, Mazoyer S. 1999a. An Alu-mediated 6-kb duplication in the BRCA1 gene: a new founder mutation? Am J Hum Genet 64:300-302.
39. Puget N, Stoppa-Lyonnet D, Sinilnikova OM, Pages S, Lynch HT, Lenoir GM, Mazoyer S. 1999b. Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions. Cancer Res 59:455-461.
40. Rouleau E, Lefol C, Bourdon V, Coulet F, Noguchi T, Soubrier F, Bieche I, Olschwang S, Sobol H, Lidereau R. 2009. Quantitative PCR high-resolution melting (q PCRHRM) curve analysis, a new approach to simultaneously screen point mutations and large rearrangements: application to MLH1 germline mutations in Lynch syndrome. Hum Mutat 30:867-875.
41. Rouleau E, Lefol C, Tozlu S, Andrieu C, Guy C, Copigny F, Nogues C, Bieche I, Lidereau R. 2007. High-resolution oligonucleotide array-CGH applied to the detection and characterization of large rearrangements in the hereditary breast cancer gene BRCA1. Clin Genet 72:199-207.
42. Schurra C, Bensimon A. 2009. Combing genomic DNA for structural and functional studies. Methods Mol Biol 464:71-90.
43. Sluiter MD, van Rensburg EJ. 2011. Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation. Breast Cancer Res Treat 125:325-349.
44. Staaf J, Torngren T, Rambech E, Johansson U, Persson C, Sellberg G, Tellhed L, Nilbert M, Borg A. 2008. Detection and precise mapping of germline rearrangements in BRCA1, BRCA2, MSH2, and MLH1 using zoom-in array comparative genomic hybridization (aCGH). Hum Mutat 29:555-564.
45. Szabo C, Masiello A, Ryan JF, Brody LC. 2000. The breast cancer information core: database design, structure, and scope. Hum Mutat 16:123-131.
46. Tournier I, Paillerets BB, Sobol H, Stoppa-Lyonnet D, Lidereau R, Barrois M, Mazoyer S, Coulet F, Hardouin A, Chompret A and others. 2004. Significant contribution of germline BRCA2 rearrangements in male breast cancer families. Cancer Res 64:8143-8147.
47. Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, Higgins J, Roach KC, Mandell J, Lee MK, Ciernikova S and others. 2006. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 295:1379-1388.
48. Walsh T, Lee MK, Casadei S, Thornton AM, Stray SM, Pennil C, Nord AS, Mandell JB, Swisher EM, King MC. 2010. Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proc Natl Acad Sci USA 107:12629-12633.
49. Yap KP, Ang P, Lim IH, Ho GH, Lee AS. 2006. Detection of a novel Alu-mediated BRCA1 exon 13 duplication in Chinese breast cancer patients and implications for genetic testing. Clin Genet 70:80-82.